瑞苏伐他汀联合曲美他嗪治疗冠心病的疗效分析

Curative Effect Analysis of Rosuvastatin Combined With Trimetazidine in the Treatment of Patients With Coronary Heart Disease

目的观察瑞苏伐他汀联合曲美他嗪治疗冠心病的临床疗效。方法选取我院收治的120例冠心病患者,将其随即分为观察组以及对照组,每组60例,对照组单纯给予曲美他嗪治疗,观察组采用瑞苏伐他汀联合曲美他嗪治疗,比较两组患者的治疗效果以及不良反应情况。结果观察组的治疗有效率为90.00%,对照组为73.33%,组间比较差异有统计学意义,χ2=5.56,P<0.05。观察组不良反应的发生率为6.67%(4/60),对照组为5.00%(3/60),两组患者在不良反应发生率方面比较无明显差异,P>0.05。结论瑞苏伐他汀联合曲美他嗪治疗冠心病可以起到很好的治疗效果。

Objective To investigate the curative effect analysis of rosuvastatin combined with trimetazidine in the treatment of patients with coronary heart disease. Methods One hundred and twenty cases of CHD were randomly and respectively assigned into observation group and control group： patients in control group were treated with trimetazidine; Patients in observation group were given rosuvastatin and trimetazidine, after 8 weeks of treatment ,to compare thetherapeutic effect of two groups. Results in the observation group total effective rate 90.00% significantly higher than the control group （73.33%）,differences were statistical significance （P〈0.05）.incidence rates of adverse reaction in two groups were no obvious difference（P〉0 .05）. Conclusion Rosuvastatin combined with trimetazidine is of efficacy in treatment of coronary heart disease.